Furthermore, the combination of the GLI1 inhibitor, GANT58, and CCR2 inhibitor, INCB3344, substantially reduced the occurrence of EHF‐mediated CCA. This evidence concerns the gene GLI1 and Ebola hemorrhagic fever.